2019-2024 Pharma Collaboration Report: Upfront, Milestones, Royalties by Company, Therapy, Tech – ResearchAndMarkets.com

The “Collaboration Deals in Pharmaceuticals 2019-2024” report is now available on ResearchAndMarkets.com.

This report offers a detailed analysis of collaboration deals in the pharmaceutical industry, explaining why and how companies enter these deals. Updated to include data from 2019 to 2024, it provides insights into payment terms and other critical details.

The report highlights the importance of understanding the flexibility in negotiation terms, especially for smaller companies. It includes a comprehensive list of collaboration deals announced since 2019, with financial terms and links to actual contract documents filed with the SEC.

Numerous tables and figures illustrate trends and activities in collaboration dealmaking. The initial chapters provide an orientation on dealmaking and business activities, including:

  • Chapter 1: Introduction
  • Chapter 2: Trends in collaboration, including the merits of different deal types
  • Chapter 3: Overview of collaboration deal structures
  • Chapter 4: Review of leading collaboration deals since 2019, including headline values and links to contracts
  • Chapter 5: Listing of the top 25 most active collaboration dealmakers with links to full deal records
  • Chapter 6: Detailed review of collaboration deals organized by company, therapy, technology, and industry type

Key Benefits:

  • Understand deal trends since 2019
  • Browse collaboration deals
  • Benchmark analysis to identify transaction market value
  • Access financial terms (upfront, milestone, royalties)
  • Directory of deals by company, therapy focus, and technology type
  • Insights into leading deals by value and most active dealmakers
  • Identify assets and deal terms for each transaction
  • Access contract documents for insights into deal structures
  • Conduct due diligence to assess proposed deal terms

Report Scope:

  • Trends in biopharma collaboration dealmaking
  • Overview of collaboration deal structures
  • Directory of pharmaceutical and biotechnology collaboration deals
  • Leading deals by value and most active dealmakers
  • Collaboration partnering resources

Key Topics Covered:

  • Executive Summary
  • Introduction to collaboration dealmaking
  • Trends in collaboration deals by year, development phase, industry sector, therapy area, technology type, and most active companies from 2019-2024
  • Reasons for entering collaboration deals
  • Future of collaboration deals
  • Overview of collaboration agreement structures
  • Top collaboration deals by value
  • Top 25 most active collaboration dealmakers
  • Comprehensive directory of collaboration deals and contracts from 2019-2024, organized by company, therapy area, and technology type

Source Link

Newsletter Updates

Enter your email address below and subscribe to our newsletter